Hill Investment Group Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721K Buy
5,614
+84
+2% +$9.83K 0.07% 36
2026
Q1
$665K Hold
5,530
0.07% 33
2025
Q4
$582K Buy
5,530
+6
+0.1% +$563 0.07% 33
2025
Q3
$464K Hold
5,524
0.06% 37
2025
Q2
$437K Buy
5,524
+53
+1% +$4.21K 0.06% 35
2025
Q1
$491K Sell
5,471
-1,690
-24% -$158K 0.07% 33
2024
Q4
$712K Sell
7,161
-23
-0.3% -$2.37K 0.1% 36
2024
Q3
$919K Sell
7,184
-49
-0.7% -$5.82K 0.13% 33
2024
Q2
$900K Buy
7,233
+75
+1% +$9.66K 0.12% 33
2024
Q1
$944K Hold
7,158
0.13% 34
2023
Q4
$780K Sell
7,158
-287
-4% -$29.8K 0.11% 37
2023
Q3
$766K Buy
7,445
+1,574
+27% +$170K 0.13% 34
2023
Q2
$677K Hold
5,871
0.12% 36
2023
Q1
$625K Hold
5,871
0.12% 37
2022
Q4
$651K Buy
+5,871
New +$600K 0.16% 33

Other funds holding MRK

Hill Investment Group Partners's MRK Position: Q2 2026 in Review

Hill Investment Group Partners increased its Merck (MRK) stake by 1.5% in Q2 2026, buying an estimated $9.83K and bringing the position to 5,614 shares worth $721K. The position accounts for 0.07% of the portfolio, ranked #36.

Hill Investment Group Partners first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $944K in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hill Investment Group Partners held 5,614 shares of Merck worth $721K as of Q2 2026.
  • Hill Investment Group Partners bought 84 Merck shares in Q2 2026, an estimated $9.83K.
  • Merck made up 0.07% of Hill Investment Group Partners's portfolio in Q2 2026, its #36 holding.
  • Hill Investment Group Partners first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Hill Investment Group Partners's Merck position peaked at $944K in Q1 2024.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hill Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.